Found 36 matching trials
Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis PHASE4 This modular Program will first confirm the safety and efficacy of Paromomy...
Show More Location
Rajendra Memorial Research Institute of Medical Sciences
Learn More & Join Trial
Phase 3 Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia) PHASE3 This study will test the ability of the topical cream WR 279,396 to treat t...
Show More Location
Central Clinic-Sidi Bouzid
Learn More & Join Trial
A Study to Assess Immune Response Status in Patients Before and After Treatment for Visceral Leishmaniasis N/A ImmStat@Cure is a multicentre observational study designed to assess the im...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Phase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in Bangladesh PHASE3 This protocol will evaluate the efficacy and safety of various combinations...
Show More Learn More & Join Trial
Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis PHASE3 The overall objective of this trial is to identify a safe and effective com...
Show More Location
Kala-azar medical centre
Learn More & Join Trial
Combination Therapy in Indian Visceral Leishmaniasis PHASE3 Rationale
The overall objective of this trial is to identify a safe and ef...
Show More Location
Kala-azar Medical Research Center
Learn More & Join Trial
WR 279,396 for the Treatment of Cutaneous Leishmaniasis PHASE2 The objectives of the study are to evaluate the safety and efficacy of open...
Show More Location
Groupe Hospitalier Pitié-Salpêtrière
Learn More & Join Trial
Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia PHASE2 This protocol will compare topical paromomycin to standard intralesional (I...
Show More Location
Hospital Local Palos Blancos
Learn More & Join Trial
A Study to Evaluate the Efficacy and Tolerance of WR279,396 for Old World Cutaneous Leishmaniasis PHASE2 This Phase 2 study is to determine whether WR279396 with occlusion (a polyu...
Show More Learn More & Join Trial
Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Topical Cream for the Treatment of Cutaneous Leishmaniasis in Panama PHASE2 The objectives of the study are to evaluate the pharmacokinetics (PK), safe...
Show More Location
Gorgas Memorial Institute Clinical Research Unit
Learn More & Join Trial